Author | Karen Reckamp, MD | OncLive

Author | Karen Reckamp, MD


Dr. Reckamp on MET-Targeting Strategies in NSCLC

July 27, 2018


Karen Reckamp, MD, co-director, Lung Cancer and Thoracic Oncology Program, medical director, Clinical Research Operations, professor, Department of Medical Oncology & Therapeutics Research, thoracic oncologist, discusses current and emerging therapeutic strategies to target MET in non-small cell lung cancer.

Dr. Reckamp on MK-2206 for the Treatment of EGFR Wild-Type NSCLC

July 28, 2014


Karen L. Reckamp, MD, discusses the results of a phase II study of the AKT inhibitor MK-2206 plus erlotinib in patients with advanced non-small cell lung cancer (NSCLC) who progressed on erlotinib.

Dr. Reckamp Evaluates the Predictive Efficacy of VeriStrat

September 14, 2012


Dr. Karen Reckamp, from City of Hope, evaluates the predictive efficacy of the pretreatment serum test VeriStrat for non-small cell lung cancer.

Dr. Reckamp Discusses the Use of Hsp90 Inhibitors

August 25, 2011


Dr. Karen Reckamp from the City of Hope Cancer Center Discusses the Use of Hsp90 Inhibitors